Rubric Capital Management LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rubric Capital Management LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,645,361
-90.5%
919,196
-79.3%
0.07%
-84.4%
Q1 2023$17,275,708
-38.7%
4,441,056
-46.5%
0.45%
-63.6%
Q4 2022$28,201,711
+29.4%
8,294,621
+107.9%
1.23%
+12.1%
Q3 2022$21,786,000
+9.8%
3,990,126
-9.3%
1.10%
+5.3%
Q2 2022$19,844,000
-25.4%
4,400,000
+22.0%
1.04%
+8.4%
Q1 2022$26,587,000
+48.6%
3,607,443
+29.7%
0.96%
+13.7%
Q4 2021$17,891,000
-8.9%
2,782,443
-17.6%
0.84%
+53.9%
Q3 2021$19,647,000
-55.2%
3,375,758
-20.6%
0.55%
-80.1%
Q2 2021$43,893,0004,253,2122.76%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders